In this review, we discuss the role of gut microbiota in obesity and NAFLD.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease in developed countries.
📊
Key Findings & Data:Accumulated evidence has revealed that gut microbial compositional changes may be associated with more energy harvesting from the diet, which promotes increased fatty acid uptake from adipose tissue and shifts lipid metabolism from oxidation to de novo production.
💡
Conclusion & Impact:In this review, we discuss the role of gut microbiota in obesity and NAFLD.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease in developed countries. Obesity is the most important risk factor for metabolic syndrome and NAFLD. Accumulated evidence has revealed that gut microbial compositional changes may be associated with more energy harvesting from the diet, which promotes increased fatty acid uptake from adipose tissue and shifts lipid metabolism from oxidation to de novo production. Furthermore, changes in intestinal barrier function contribute to metabolic endotoxemia in the form of low-grade microbial inflammation. Persistent inflammation exacerbates NAFLD progression. In this review, we discuss the role of gut microbiota in obesity and NAFLD.
🔖
Cite This Article
GANGARAPU, V., YILDIZ, K., İNCE, A. T., BAYSAL, B. (2014). Role of gut microbiota: Obesity and NAFLD. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 2, 133–140. https://ajindex.com/articles/411451
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellen- tani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology 2005
[CrossRef] Edmison J, Mc Cullough AJ. Pathogenesis of non-alcoholic steato- hepatitis: Human data. Clin Liver Dis 2007
[CrossRef] Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver dis- ease in China. J Hepatol 2009
[CrossRef] Fan JG, Jia JD, Li YM et al. Guidelines for the diagnosis and man- agement of non-alcoholic fatty liver disease: Update 2010: (pub- lished in Chinese on Chinese Journal of Hepatology 2010
. J Dig Dis 2011
[CrossRef] Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and man- agement of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Associa- tion for the Study of Liver Diseases, and American College of Gas- troenterology. Gastroenterology. 2012
[CrossRef] Abu-Shanab A, Quigley EM. The role of the gut microbiota in non- alcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010
[CrossRef] Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gas- trointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 2004
[CrossRef] Backhed F, Ding H, Wang T, et al. The gut microbiota as an envi- ronmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004
15718-23. [CrossRef] Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006
[CrossRef] Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007
[CrossRef] Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gor- don JI. An obesity-associated gut microbiome with increased ca- pacity for energy harvest. Nature 2006
[CrossRef] Jumpertz R, Le DS, Turnbaugh PJ, et al. Energy-balance studies re- veal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011
[CrossRef] Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgro